coartem baby
coartem baby: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: Novartis AG (NVS)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Novartis AG (NVS) | Phase 4 |
Clinical Trials (1)
A Multi-centre, Open-label, Non-comparative Study to Assess Safety and Clinical Response With Coartem® Baby Dispersible Tablets in Paediatric Patients (≥ 2 to <5 kg) With Uncomplicated Malaria Due to Plasmodium Falciparum or Mixed Infections
Frequently asked questions
Who is developing coartem baby?
coartem baby is being developed by Novartis AG.
How many clinical trials involve coartem baby?
BioSniper tracks 1 clinical trial involving coartem baby.
Analyze Novartis AG & coartem baby with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company